Phase III studies of Xolair in chronic rhinosinusitis with nasal polyps meet coprimary endpoints June 3, 2019
Phase III QUARTZ study of QMF-149 in inadequately controlled asthma meets primary endpoint May 30, 2019
BLU-5937: P2X3 homotrimeric receptor antagonist with improved taste safety profile for cough May 27, 2019